Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 6
Submit an article Journal homepage
429
Views
7
CrossRef citations to date
0
Altmetric
Letters to the Editor

Modified CLL International Prognostic Index (CLL-LIPI) using lymphocyte doubling time (LDT) in place of IgHV mutation status in resource-limited settings predicts time to first treatment and overall survival

Deepesh P. LadDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3754-7774
ORCID Icon,
V. TejaswiDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Nishant JindalDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Pankaj MalhotraDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Alka KhadwalDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Gaurav PrakashDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Arihant JainDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
,
Sreejesh SreedharanunniDepartment of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Manupdesh Singh SachdevaDepartment of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Shano NaseemDepartment of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Neelam VarmaDepartment of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
&
Subhash VarmaDepartment of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;
show all
Pages 1512-1515 | Received 22 Oct 2019, Accepted 09 Jan 2020, Published online: 29 Jan 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Estella Matutes & Aaron Polliack. (2020) The challenge of unavailable IGH mutational status in CLL in resource-limited settings. Leukemia & Lymphoma 61:6, pages 1275-1276.
Read now

Articles from other publishers (6)

Aleksina Shatilova, Larisa Girshova, Daniil Zaytsev, Irina Budaeva, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Dmitriy Motorin, Darina Zammoeva, Svetlana Efremova, Vladimir Ivanov, Alexey Petukhov, Yuliya Alekseeva & Andrey Zaritskey. (2021) The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report. BMC Women's Health 21:1.
Crossref
Fortunato Morabito, Giovanni Tripepi, Riccardo Moia, Anna Grazia Recchia, Paola Boggione, Francesca Romana Mauro, Sabrina Bossio, Graziella D’Arrigo, Enrica Antonia Martino, Ernesto Vigna, Francesca Storino, Gilberto Fronza, Francesco Di Raimondo, Davide Rossi, Adalgisa Condoluci, Monica Colombo, Franco Fais, Sonia Fabris, Robin Foa, Giovanna Cutrona, Massimo Gentile, Emili Montserrat, Gianluca Gaidano, Manlio Ferrarini & Antonino Neri. (2021) Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia. Frontiers in Oncology 11.
Crossref
Tycho Baumann, Riccardo Moia, Gianluca Gaidano, Julio Delgado, Adalgisa Condoluci, Neus Villamor, Anil Babu Payedimarri, Dolors Costa, Andrea Patriarca, Carlos Jiménez-Vicente, Davide Rossi & Emili Montserrat. (2021) Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients. Leukemia 35:8, pages 2325-2331.
Crossref
Charanpreet Singh, Nishant Jindal, Padma Youron, Pankaj Malhotra, Gaurav Prakash, Alka Khadwal, Arihant Jain, Sreejesh Sreedharanunni, Man Updesh Singh Sachdeva, Shano Naseem, Neelam Varma, Subhash Varma & Deepesh P. Lad. (2020) Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients. Indian Journal of Hematology and Blood Transfusion 37:2, pages 313-317.
Crossref
Xiaoya Yun, Ya Zhang & Xin Wang. (2020) Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia. Biomarker Research 8:1.
Crossref
Padma Youron, Charanpreet Singh, Nishant Jindal, Pankaj Malhotra, Alka Khadwal, Arihant Jain, Gaurav Prakash, Neelam Varma, Subhash Varma & Deepesh P. Lad. (2020) Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ‐C30 and QLQ‐CLL17 questionnaire. European Journal of Haematology 105:6, pages 755-762.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.